You can find the annual or quarterly income statement of LB Pharmaceuticals Inc here for insights into the performance and operational efficiency of LB Pharmaceuticals Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating expenses
--5.25M
R&D expenses
--2.42M
Depreciation, depletion, and amortization
--81.00K
Operating profit
---5.25M
Net non-operating interest income (expenses)
Non-operating interest income
--707.00K
Gains from sale of securities
--0.00
Special income (expenses)
--983.00K
Income before tax
---3.56M
Income tax
--0.00
Income after tax
---3.56M
Net income from continuous operations
---3.56M
Net income attributable to controlling interests
---3.56M
Net income attributable to common shareholders
---3.56M
Basic earnings per share
---0.14
Diluted earnings per share
---0.14
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.